Towards Personalised Medicine for Inflammatory Skin Diseases
BIOMAP will examine the causes and mechanisms of Atopic Dermatitis and Psoriasis to enable optimal treatments and an individualised therapy scheme for each patient.
Atopic Dermatitis and Psoriasis affect more than 300 million people worldwide and are highly variable in terms of onset, severity, progression over time and response to treatment.
21.2 Mio €
Introduction to BIOMAP
High disease heterogeneity
Outdated disease classification
Limited understanding of underlying mechanisms
Lack of biomarkers for disease and therapy prediction
Insufficient infrastructure for global access to samples and data